Your browser doesn't support javascript.
loading
Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells.
Fiskus, Warren; Mill, Christopher P; Nabet, Behnam; Perera, Dimuthu; Birdwell, Christine; Manshouri, Taghi; Lara, Bernardo; Kadia, Tapan M; DiNardo, Courtney; Takahashi, Koichi; Daver, Naval; Bose, Prithviraj; Masarova, Lucia; Pemmaraju, Naveen; Kornblau, Steven; Borthakur, Gautam; Montalban-Bravo, Guillermo; Manero, Guillermo Garcia; Sharma, Sunil; Stubbs, Matthew; Su, Xiaoping; Green, Michael R; Coarfa, Cristian; Verstovsek, Srdan; Khoury, Joseph D; Vakoc, Christopher R; Bhalla, Kapil N.
Afiliación
  • Fiskus W; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Mill CP; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Nabet B; Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
  • Perera D; Department of Molecular and Cellular Biology Baylor College of Medicine, Houston, TX, USA.
  • Birdwell C; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Manshouri T; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Lara B; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Kadia TM; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • DiNardo C; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Takahashi K; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Daver N; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Bose P; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Masarova L; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Pemmaraju N; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Kornblau S; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Borthakur G; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Montalban-Bravo G; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Manero GG; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Sharma S; The Translational Genomics Research Institute (TGen), Phoenix, AZ, USA.
  • Stubbs M; Incyte Corporation, Wilmington, DE, USA.
  • Su X; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Green MR; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Coarfa C; Department of Molecular and Cellular Biology Baylor College of Medicine, Houston, TX, USA.
  • Verstovsek S; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Khoury JD; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Vakoc CR; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
  • Bhalla KN; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. kbhalla@mdanderson.org.
Blood Cancer J ; 11(5): 98, 2021 05 20.
Article en En | MEDLINE | ID: mdl-34016956
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Leucemia Mieloide Aguda / Proteínas de Ciclo Celular / Proteínas de Unión al ADN / Histona Demetilasas / Trastornos Mieloproliferativos / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Leucemia Mieloide Aguda / Proteínas de Ciclo Celular / Proteínas de Unión al ADN / Histona Demetilasas / Trastornos Mieloproliferativos / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos